Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Anybody else around here...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2401)
•••
Comment by JDavenporton Nov 24, 2020 1:28pm
309 Views
Post# 31961869

RE:Anybody else around here...

RE:Anybody else around here...Why, thanks, snipes! I have some insights to offer, including one called "Things That Wouldn't Surprise Me," coming your way, it wouldn't surprise me, this afternoon. It's a post that I have rewritten about six times since the Chiesi deal. (...although I have been discussing the subject matter with several shareholders for many months.)

Also, my website, which has been a troublesome consideration for me, will be called "StoxComm" for reasons that I'll explain on the site when I put it up. Putting a web site up takes only moments to do. Creating the purpose and content takes forever, but I think I have an idea, at last, of what I want the website to do and say, and what I'm actually prepared to do with it. It really only hit me in the last few days what's possible with it. The site's URLs will be stoxcomm.com and stoxcomm.ca, either one will work. It should be live by Dec 3, because our anniversary is on the 4th and I want the damn thing up and running by then.

Free insight #1: Some folks should not eat cabbage late in the evening.

Davenport
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities